Combined p53 and MDM2 biomarker analysis shows a unique pattern of expression associated with poor prognosis in patients with renal cell carcinoma undergoing radical nephrectomy

Aidan P. Noon(Cancer Research UK), Mark T. Boyd(University of Liverpool), Bryony H. Lloyd(University of Liverpool), Sarah E. Coupland(University of Liverpool), Howida Shawki, Nikolina Vlatković(University of Liverpool), Radosław Polański(AstraZeneca (United Kingdom)), Helen Kalirai, Keith Parsons(University of Liverpool), Fiona Campbell(University of Birmingham), Ashraf Y. El‐Fert, D. Ross Sibson(University of Liverpool), Richard Eccles(University of Liverpool), Sarah L. Lake, Andy Dodson
British Journal of Urology
July 14, 2011
Cited by 35


Related Papers